Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −8 vs. Q2 2022
- Shares held
- 27.6M
- −2.16M (−7.2%) vs. Q2 2022
- Total value
- $30.4M
- −$5.66M (−15.7%) vs. Q2 2022
- New holders
- 5
- 12 more added
- Sold out
- 13
- 17 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 3,948,360 | $4.34M | 0.13% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $3.90M | 0.43% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,365,064 | $2.60M | 0.07% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,320,381 | $2.55M | 4.35% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $2.28M | 0.01% | 00.0% | Unchanged |
| Novo Holdings A/S | 1,950,000 | $2.15M | 0.10% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,674,166 | $1.84M | 0.23% | +126,456+8.2% | Added |
| Adage Capital Partners GP, L.L.C. | 1,473,278 | $1.62M | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,148,142 | $1.26M | 0.00% | +10,371+0.9% | Added |
| Vanguard Group Inc | 1,089,992 | $1.20M | 0.00% | +27,320+2.6% | Added |
| Newtyn Management, LLC | 1,000,000 | $1.10M | 0.24% | +37,912+3.9% | Added |
| Point72 Asset Management, L.P. | 917,036 | $1.01M | 0.00% | +117,036+14.6% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $818.0K | 0.30% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 730,598 | $804.0K | 0.00% | −172,502−19.1% | Reduced |
| BlackRock Inc. | 517,559 | $569.0K | 0.00% | −7,997−1.5% | Reduced |
| Acadian Asset Management LLC | 334,704 | $366.0K | 0.00% | +20,370+6.5% | Added |
| Millennium Management LLC | 332,131 | $365.0K | 0.00% | −132,278−28.5% | Reduced |
| New York Life Investment Management LLC | 234,100 | $258.0K | 0.00% | +17,198+7.9% | Added |
| Geode Capital Management, LLC | 190,418 | $209.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 124,426 | $137.0K | 0.00% | −70,986−36.3% | Reduced |
| Two Sigma Advisers, LP | 117,500 | $129.0K | 0.00% | +5,300+4.7% | Added |
| HRT Financial LP | 101,772 | $111.0K | 0.00% | −34,814−25.5% | Reduced |
| Bridgeway Capital Management, LLC | 79,000 | $87.0K | 0.00% | +22,000+38.6% | Added |
| Rockefeller Capital Management L.P. | 77,499 | $85.0K | 0.00% | +77,499 | New |
| Citadel Advisors LLC | 73,295 | $80.0K | 0.00% | −85,644−53.9% | Reduced |
| Deutsche Bank AG | 71,290 | $78.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 60,823 | $67.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 52,889 | $58.0K | 0.00% | −50,811−49.0% | Reduced |
| Oasis Management Co Ltd. | 45,797 | $50.0K | 0.01% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 37,981 | $42.0K | 0.00% | −6,668−14.9% | Reduced |
| Northern Trust Corp | 32,604 | $36.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 31,568 | $35.0K | 0.00% | −123,300−79.6% | Reduced |
| HarbourVest Partners LLC | 18,783 | $21.0K | 0.01% | 00.0% | Unchanged |
| Bailard, Inc. | 19,400 | $21.0K | 0.00% | +19,400 | New |
| Qube Research & Technologies Ltd | 16,031 | $18.0K | 0.00% | −2,658−14.2% | Reduced |
| Goldman Sachs Group Inc | 14,043 | $15.0K | 0.00% | −84,916−85.8% | Reduced |
| Balyasny Asset Management LLC | 11,999 | $13.0K | 0.00% | +11,999 | New |
| Gsa Capital Partners LLP | 10,513 | $12.0K | 0.00% | −10,205−49.3% | Reduced |
| Morgan Stanley | 10,282 | $11.0K | 0.00% | −42,331−80.5% | Reduced |
| Tower Research Capital LLC (TRC) | 8,062 | $9.00K | 0.00% | −10,577−56.7% | Reduced |
| Advisor Group Holdings, Inc. | 8,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,802 | $5.00K | 0.00% | +2,230+141.9% | Added |
| Federated Hermes, Inc. | 2,017 | $2.00K | 0.00% | +2,017 | New |
| Citigroup Inc | 563 | $1.00K | 0.00% | −1,049−65.1% | Reduced |
| FMR LLC | 1,013 | $1.00K | 0.00% | +532+110.6% | Added |
| Capital Advisors, Ltd. LLC | 667 | $1.00K | 0.00% | −220−24.8% | Reduced |
| Cubist Systematic Strategies, LLC | 26 | $0 | 0.00% | −3,836−99.3% | Reduced |
| Wells Fargo & Company | 169 | $0 | 0.00% | +44+35.2% | Added |
| Royal Bank of Canada | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 115 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 37 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 372 | $0 | 0.00% | +372 | New |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,526,048−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −73,986−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −58,392−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −48,045−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −29,302−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −22,685−100.0% | Sold out |
| Wedmont Private Capital | 0 | $0 | 0.00% | −20,741−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,036−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −13,489−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −4,552−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,933−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |